Publications

Title

Author

Year

Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.

Agnandji, ST; ASANTE, KP; Lyimo, J; Vekemans, J; Soulanoudjingar, SS; Owusu, R; Shomari, M; Leach, A; Fernandes, J; DOSOO, D; Chikawe, M; Issifou, S; Osei-Kwakye, K; Lievens, M; Paricek, M; Apanga, S; Mwangoka, G; Okissi, B; Kwara, E; Minja, R; Lange, J; Boahen, O; Kayan, K; Adjei, G; CHANDRAMOHAN, D; ... Abdulla, S.

2010

The Journal of infectious diseases, (2010).202 7 10.1086/656190.

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.

JOBARTEH, M; Malfroy, M; Peterson, I; Jeng, A; Sarge-Njie, R; Alabi, A; Peterson, K; COTTEN, M; Hall, A; Rowland-Jones, S; Whittle, H; Tedder, R; Jaye, A; Mendy, M;

2010

Virology journal, (2010).7 1 10.1186/1743-422X-7-230.

Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis.

Weinberger, DM; Harboe, ZB; Sanders, EA M; Ndiritu, M; Klugman, KP; Rückinger, S; Dagan, R; Adegbola, R; Cutts, F; Johnson, HL; O'Brien, KL; SCOTT, JA; Lipsitch, M;

2010

Clinical infectious diseases, (2010).51 6 10.1086/655828.

Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon.

Mordmüller, B; Szywon, K; Greutelaers, B; Esen, M; Mewono, L; Treut, C; Mürbeth, RE; Chilengi, R; Noor, R; Kilama, WL; Imoukhuede, EB; Imbault, N; Leroy, O; Theisen, M; Jepsen, S; MILLIGAN, P; Fendel, R; Kremsner, PG; Issifou, S;

2010

Vaccine, (2010).28 41 10.1016/j.vaccine.2010.07.085.

A brief history of economic evaluation for human papillomavirus vaccination policy.

Beutels, P; JIT, M;

2010

Sexual health, (2010).7 3 10.1071/SH10018.

Invasive pneumococcal disease in Fiji: clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine.

Russell, FM; Carapetis, JR; Tikoduadua, L; Paeds, D; Chandra, R; Seduadua, A; Satzke, C; Pryor, J; Buadromo, E; Waqatakirewa, L; MULHOLLAND, EK;

2010

The Pediatric infectious disease journal, (2010).29 9 10.1097/INF.0b013e3181ec7ae2.

Estimating the proportion of pneumonia attributable to pneumococcus in Kenyan adults: latent class analysis.

Jokinen, J; SCOTT, JA G;

2010

Epidemiology (Cambridge, Mass), (2010).21 5 10.1097/EDE.0b013e3181e4c4d5.

Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya.

Osier, FH A; Weedall, GD; Verra, F; Murungi, L; TETTEH, KK A; Bull, P; Faber, BW; Remarque, E; Thomas, A; Marsh, K; CONWAY, DJ;

2010

Infection and immunity, (2010).78 11 10.1128/IAI.00576-10.

Doxorubicin-loaded and antibody-conjugated liposome-QD hybrid vesicles for targeted cancer therapy and imaging.

Tian, B; Al-Jamal, WT; Van den Bossche, J; Stuart, M; RAYNES, JG; Kostarelos, K;

2010

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, (2010).240,

The India HPV-vaccine suspension.

LARSON, HJ; Brocard, P; GARNETT, G;

2010

Lancet, (2010).376 9741 10.1016/S0140-6736(10)60881-1.